NIH-funded research R01 grant

New treatments for brain metastasis in cancer patients

Official title: Developing new therapeutic strategies for brain metastasis

Funded at New York University School of Medicine · NIH-11008918 · Data updated 2026-11-12

This study is looking at how cancer spreads to the brain, especially in patients with melanoma, lung cancer, and breast cancer, to see if treatments for Alzheimer’s disease can help fight these brain tumors.

More Metastasis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$548,753
NIH project number5R01CA277425-03
Project IDNIH-11008918 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer patients diagnosed with melanoma, lung, or breast adenocarcinoma who are at risk of developing brain metastasis.

Less likely to help

Patients with brain metastasis from cancers other than melanoma, lung, or breast adenocarcinoma may not benefit from this research.

What this research studies

This research investigates the mechanisms behind brain metastasis in cancer patients, particularly those with melanoma, lung, and breast adenocarcinomas. By developing a model using patient-derived cultures, the researchers aim to understand how brain metastases differ from other types of metastases. They are exploring the role of amyloid-beta (Aβ) in brain metastasis and hypothesize that existing Alzheimer’s treatments targeting Aβ can be repurposed to combat brain metastasis. The study employs advanced techniques such as proteomics and in vitro assays to identify potential therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients with brain metastasis, potentially improving survival rates and quality of life.

How similar studies have gone: Other research has shown promise in repurposing Alzheimer’s treatments for different conditions, suggesting potential success for this novel approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Hernando, Eva — New York University School of Medicine
  • Study coordinator: Hernando, Eva

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.